Crossmark

Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis

Published Online: 2022-04-09

Published Print: 2022-08

Authors

Li, Xiaohui https://orcid.org/0000-0002-7022-8970
Jia, Zetian https://orcid.org/0000-0003-0624-5634
Yan, Yaqi https://orcid.org/0000-0003-3915-4966
License Information

Text and Data Mining valid from 2022-04-09

Version of Record valid from 2022-04-09
More Information

Article History

Received: 3 December 2021

Accepted: 23 March 2022

First Online: 9 April 2022

Declarations

:

: The authors declare no competing interests.Consent for publication.All authors read the manuscript and agree to publish the paper.

Document is current